THE MOLECULAR CANCER SUBTYPES VERSUS THE INDUSTRY ARSENAL. WHICH ONE DRIVES GASTRIC CANCER TREATMENT? [PDF]
Assumpção PP, Kassab P.
europepmc +1 more source
LONG-TERM SURVIVAL AFTER LAPAROSCOPIC TOTAL GASTRECTOMY FOR EARLY AND ADVANCED GASTRIC CANCER. SINGLE CENTER EXPERIENCE IN 100 CASES. [PDF]
Norero E +7 more
europepmc +1 more source
PERIOPERATIVE CHEMOTHERAPY, ADJUVANT CHEMOTHERAPY AND ADJUVANT CHEMORADIOTHERAPY IN THE SURGICAL TREATMENT OF GASTRIC CANCER IN A HOSPITAL OF THE BRAZILIAN UNIFIED HEALTH SYSTEM. [PDF]
Pracucho EM +3 more
europepmc +1 more source
ARE THERE ADVANTAGES IN DOUBLE TRANSIT RECONSTRUCTION AFTER TOTAL GASTRECTOMY IN PATIENTS WITH GASTRIC CANCER? A SYSTEMATIC REVIEW. [PDF]
Costa LCDS +10 more
europepmc +1 more source
RATIO OF METASTATIC LYMPH NODES VS. RESECTED LYMPH NODES (N-RATIO) HAS PROGNOSTIC IMPLICATIONS IN GASTRIC CANCER. [PDF]
Porto BC +6 more
europepmc +1 more source
TUMOR MARKERS EXPRESSION LEVELS IN GASTRIC CANCER PATIENT'S PERIPHERAL BLOOD BY RT-PCR ASSESSMENT. [PDF]
Kawakami GDS +5 more
europepmc +1 more source
PALLIATIVE GASTRECTOMY VERSUS GASTRIC BYPASS FOR SYMPTOMATIC CLINICAL STAGE IV GASTRIC CANCER: A PROPENSITY SCORE MATCHING ANALYSIS. [PDF]
Pinto SOSA +4 more
europepmc +1 more source
MINIMALLY INVASIVE SURGERY FOR GASTRIC CANCER: PARADIGM SHIFT. [PDF]
Ramos MFKP +3 more
europepmc +1 more source
BRAZILIAN GASTRIC CANCER ASSOCIATION GUIDELINES (PART 1): AN UPDATE ON DIAGNOSIS, STAGING, ENDOSCOPIC TREATMENT AND FOLLOW-UP. [PDF]
Barchi LC +60 more
europepmc +1 more source
INTRODUCTION OF THE NEW LYMPHOPARIETAL INDEX FOR GASTRIC CANCER PATIENTS. [PDF]
Figueroa-Giralt M +7 more
europepmc +1 more source

